Nicotinic and Glycinergic Medications for Disorders of Hedonic Regulation

E-ISSN： 1875-628x|4|5|373-381

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.4, Iss.5, 2007-07, pp. : 373-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of nicotinic drug therapy for cognitive disorders

By Levin E.D. Rezvani A.H.

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

Nicotine and Nicotinic Receptor Involvement in Neuropsychiatric Disorders

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-01 ,pp. : 267-282

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors as Therapeutic Targets for Drug Addictive Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 5, 2013-08 ,pp. : 633-640

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Psychiatric Medications on Sleep and Sleep Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 1, 2007-02 ,pp. : 17-29

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

By Verrico Christopher D Haile Colin N Newton Thomas F Kosten Thomas R De La Garza Richard

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1549-1568

Informa Healthcare

Access to resources Recommend Favorite